All News
Filter News
Found 808,690 articles
-
Ultroid Technologies, Inc. Appoints New CEO
12/15/2009
-
Roberto Bellini Appointed President and CEO of BELLUS Health
12/15/2009
-
Coffee, Tea May Stall Diabetes, University of Sydney Study
12/15/2009
-
Medical Devices Effect on Health Care Reform
12/15/2009
-
Immune-Boosting Drugs Could Enhance Cancer Treatment, University of London Study
12/15/2009
-
Hospira, Inc. (JOBS) to Acquire Orchid Chemicals & Pharmaceuticals Ltd.'s Generic Injectable Pharmaceuticals Business for Approximately $400 Million
12/15/2009
-
Portable Test Devices 'Can Detect Cancer In Blood', Yale University Study
12/15/2009
-
Milk Thistle May Limit Liver Damage From Chemo, Columbia-Presbyterian Medical Center Study
12/15/2009
-
Sanofi-Aventis (France) Recalls 800000 H1N1 Vaccine Over Potency
12/15/2009
-
Elan Corporation PLC and Transition Therapeutics Inc. Drop Top Drug Doses After Nine Alzheimer's Patient Deaths
12/15/2009
-
Lytix Biopharma Announces Regulatory Approval by Norwegian and Swedish Authorities to Commence Phase I Clinical Trial of Oncopore(TM) (LTX-315) in Cancer
12/15/2009
-
Accumetrics, Inc. Closes 2009 with Positive Outlook
12/15/2009
-
Fake Blood Cells So Agile They Can Carry Drugs, University of California, Santa Barbara Study
12/15/2009
-
ViraCor-IBT Laboratories Names Dr. Mark Roberts President and Chief Executive Officer
12/15/2009
-
Alexza Pharmaceuticals, Inc. Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
12/15/2009
-
Jazz Pharmaceuticals, Inc. Submits New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
12/15/2009
-
Human Genome Sciences, Inc. Announces Submission of Marketing Authorization Application to EMEA for JOULFERON(R) (ZALBIN(TM))
12/15/2009
-
Cyclacel Pharmaceuticals, Inc. Provides Update on Meeting With FDA to Discuss Pivotal Study Design for Sapacitabine
12/15/2009
-
Generex Biotechnology Corporation Clarifies Previous Announcement of Breast Cancer Study Interim Results
12/15/2009
-
Positive Phase IIb Topline Clinical Data for Celgene Oral Compound Apremilast (CC-10004) Reported for Patients with Moderate-to-Severe Psoriasis
12/15/2009